John Edwards has 30 years of experience in discovery, development, and global commercialisation of biopharmaceuticals, involving over 10 FDA approved biologics at a series of successful biotechnology companies. Most recently John helped lead Adnexus from a start-up to the $450M acquisition by BMS within 4 years, where he then continued with the company for next 3 years serving as President.
Prior to joining Adnexus, John was Vice President of Sales, Marketing, and Medical Affairs at Transkaryotic Therapies. Additionally, during his 15-year tenure with Genetics Institute/Wyeth, John held senior-level positions in research and development, manufacturing, and commercial operations, during which time he built what has become a >$1B global pharmaceutical business in hematology. Following the acquisition of Genetics Institute by Wyeth he held senior-level positions in U.S. and global marketing at Wyeth, where he successfully launched four products in three different therapeutic areas (hematology, oncology, and immunology).
John started his career at Genzyme (pre-IPO), working in research and development. John received his M.B.A. from Boston University (class valedictorian) and his B.S. in Chemical Engineering from the University of Massachusetts at Amherst. Currently, John serves as executive chairman of F-star and ImmuneXcite.
Nalân Utku, MD is currently Managing Director of Research & Development CellAct Pharma GmbH which she co-founded. Previously Dr. Utku founded GenPat77 Pharmacogenetics AG in 1998 and served as its President, Chief Scientific Officer and Chief Executive Officer. She has more than 18 years of experience in immunological research, thereof 10 years in commercial environments. She spent several years in clinical medicine at the departments of Neurology and Rheumatology at the University of Bonn and Transplant Immunology, Renal Division, Department of Medicine at Brigham and Women's Hospital, Harvard Medical School, Boston. She started as research fellow at the department of Medicine, Brigham and Womens's Hospital, Harvard Medical School, Boston, USA in 1993. She served as a Principal Investigator in the Department of Immunology of the Charité Hospital in Berlin, where she led her own research laboratory. Dr. Utku studied Medicine at the Universities of Münster, Bonn in Germany and Pittsburgh, Pennsylvania in the USA.